Tokyo, Jan. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060280) titled 'Effect of dotinurad on proteinuria in patients with hyperuricemia' on Jan. 8.
Study Type:
Observational
Primary Sponsor:
Institute - Ibaraki prefectural central hospital,Ibraki cancer center
Condition:
Condition - Patients with hyperuricemia and proteinuria
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the effect of dotinurad on reducing proteinuria in patients with hyperuricemia and proteinuria.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria...